Joel Oyama in Woodburn, Oregon

Home Oregon Woodburn

Joel Oyama has Nurse Practitioner as his primary medical specialty. Their primary office is: 1475 Mount Hood Ave in Woodburn, Oregon. There are 2 additional office locations for Joel Oyama that can be viewed towards the end of their profile.

They're a part of the: Silverton Health medical group which has around 105 members. You can call their office at 503-982-2174 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2020 (around 4 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Joel Masami Oyama Office Phone and Directions

Joel Oyama
Silverton Health
1475 Mount Hood Ave
Woodburn, Oregon 97071
503-982-2174

Patient Ratings
Please rate your experience with Joel Oyama below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 503-982-2174

Enter a starting address:

Healthcare Info for Joel Oyama

Medical School: Sorry, his university is not listed
Graduation Year: 2020
The Primary Medical Specialty for Joel Oyama is listed as: Nurse Practitioner
Approximate Years of Experience: 4
PAC (PECOS ID)#: 9739595042
NPI #: 1154915338
NPI Created On: 02/27/2021
NPI Last Updated Listed as: 04/07/2021
Primary Taxonomy Code: 363LF0000X
License Number:
202101694NP-PP
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 838497965

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTILIPEMIC AGENTS

Name of Drug #1: NEXLIZET

Open Associated Drug #1: 72426-818-03

Drug or Biological: Drug

Product Category #2: ANTILIPEMIC AGENTS